Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2011, Article ID 385074, 4 pages
http://dx.doi.org/10.1155/2011/385074
Case Report

Systemic Mastocytosis Associated with Splenic Marginal Zone Lymphoma with Villous Lymphocytes

1Departments of Dermatology, Complejo Hospitalario Universitario A Coruña, Sir John Moore S/N, 15001 La Coruña, Spain
2Departments of Pathology, Complejo Hospitalario Universitario A Coruña, Sir John Moore S/N, 15001 La Coruña, Spain
3Departments of Haematology, Complejo Hospitalario Universitario A Coruña, Sir John Moore S/N, 15001 La Coruña, Spain

Received 22 November 2010; Revised 5 June 2011; Accepted 9 June 2011

Academic Editor: Dražen Jukić

Copyright © 2011 R. Fernández-Torres et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. P. Horny, D. D. Metcalfe, J. M. Bennett et al., “Mastocytosis,” in WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., pp. 54–63, International Agency for Research and Cancer, Lyon, France, 4th edition, 2008. View at Google Scholar
  2. D. Catovsky and E. Matutes, “Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma,” Seminars in Hematology, vol. 36, no. 2, pp. 148–154, 1999. View at Google Scholar · View at Scopus
  3. H. P. Horny, K. Sotlar, W. R. Sperr, and P. Valent, “Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge,” Journal of Clinical Pathology, vol. 57, no. 6, pp. 604–608, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. W. R. Sperr, H. P. Horny, K. Lechner, and P. Valent, “Clinical and biologic diversity of leukemias occurring in patients with mastocytosis,” Leukemia and Lymphoma, vol. 37, no. 5-6, pp. 473–486, 2000. View at Google Scholar · View at Scopus
  5. H. P. Horny, M. Ruck, M. Wehrmann, and E. Kaiserling, “Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders,” British Journal of Haematology, vol. 76, no. 2, pp. 186–193, 1990. View at Google Scholar · View at Scopus
  6. A. Pardanani, K. H. Lim, T. L. Lasho et al., “Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies,” Blood, vol. 114, no. 18, pp. 3769–3772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. W. D. Travis, C. Y. Li, E. J. Bergstralh, L. T. Yam, and R. G. Swee, “Systemic mast cell disease. Analysis of 58 cases and literature review,” Medicine, vol. 67, no. 6, pp. 345–368, 1988. View at Google Scholar · View at Scopus
  8. W. D. Travis, C. Y. Li, L. T. Yam, E. J. Bergstralh, and R. G. Swee, “Significance of systemic mast cell disease with associated hematologic disorders,” Cancer, vol. 62, no. 5, pp. 965–972, 1988. View at Google Scholar · View at Scopus
  9. K. Sotlar, T. Marafioti, H. Griesser et al., “Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia,” Journal of Clinical Pathology, vol. 53, no. 4, pp. 188–193, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Kim, L. M. Weiss, Y. Y. Chen, and V. Pullarkat, “Distinct clonal origins of systemic mastocytosis and associated B-cell lymphoma,” Leukemia Research, vol. 31, no. 12, pp. 1749–1754, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Akin, A. S. Kirshenbaum, T. Semere, A. S. Worobec, L. M. Scott, and D. D. Metcalfe, “Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis,” Experimental Hematology, vol. 28, no. 2, pp. 140–147, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. R. I. Parker, “Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease,” Journal of Investigative Dermatology, vol. 96, no. 3, 1991. View at Google Scholar · View at Scopus
  13. A. S. Worobec, “Treatment of systemic mast cell disorders,” Hematology/Oncology Clinics of North America, vol. 14, no. 3, pp. 659–687, 2000. View at Google Scholar · View at Scopus
  14. K. Brockow, L. M. Scott, A. S. Worobec et al., “Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease,” Archives of Dermatology, vol. 138, no. 6, pp. 785–790, 2002. View at Google Scholar · View at Scopus